RankAlpha logo
Back to Rankings

PACB

Pacific Biosciences of CaliforniaD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
PACB vs peer average
40/100
PACB vs. peer average (D vs. C)
Grade spread
A 1 · B 1 · C 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

PALI is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $374.68M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPALIPalisade Bio
PACB
Pacific Biosciences of California
PALI
Palisade Bio
Grade
D
C
Momentum
45
85
Value
41
41
Sentiment
-
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs PALI

PACB / PALI
Grade Position
Below peers
PACB vs. peer average (D vs. C)
40/100
Momentum
45
PALI
Value
41
PACB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PACB
1
PALI
Palisade Bio Inc Common
C
60/100
-1
2
ENTA
Enanta Pharmaceuticals Inc Common
F
20/100
+1
3
RCKT
Rocket Pharmaceuticals Inc Common
B
80/100
-2
4
STRO
Sutro Biopharma Inc Common
A
100/100
-3
5
CATX
Perspective Therapeutics Inc Common
C
60/100
-1
PALI is the first peer returned for this comparison set.